113 related articles for article (PubMed ID: 17128313)
41. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Tretjakovs P; Jurka A; Bormane I; Mikelsone I; Elksne K; Krievina G; Reihmane D; Verbovenko J; Bahs G
Clin Chim Acta; 2012 Jan; 413(1-2):25-9. PubMed ID: 22024218
[TBL] [Abstract][Full Text] [Related]
42. [P-selectin and E-selectin in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Okoń K; Twardowski R
Pol Arch Med Wewn; 2001 Dec; 106(6):1137-44. PubMed ID: 12026533
[TBL] [Abstract][Full Text] [Related]
43. Augmented platelet reactivity and thromboxane A2 production possible aggravating factors in unstable angina.
Tada M; Hoshida S; Kuzuya T
Jpn Circ J; 1986 Feb; 50(2):181-7. PubMed ID: 3723780
[TBL] [Abstract][Full Text] [Related]
44. Increased neutrophil-platelet adhesion in patients with unstable angina.
Ott I; Neumann FJ; Gawaz M; Schmitt M; Schömig A
Circulation; 1996 Sep; 94(6):1239-46. PubMed ID: 8822975
[TBL] [Abstract][Full Text] [Related]
45. [Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin].
Gao L; Li YJ; Chen KY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):300-3. PubMed ID: 18543479
[TBL] [Abstract][Full Text] [Related]
46. Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.
Hutton I; Tweddel AC; Rankin AC; Walker ID; Davidson JF
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):79S-82S. PubMed ID: 6681709
[TBL] [Abstract][Full Text] [Related]
47. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules.
Mulvihill NT; Foley JB; Murphy RT; Curtin R; Crean PA; Walsh M
Heart; 2001 Jun; 85(6):623-7. PubMed ID: 11359739
[TBL] [Abstract][Full Text] [Related]
48. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome.
Nomura S; Uehata S; Saito S; Osumi K; Ozeki Y; Kimura Y
Thromb Haemost; 2003 Mar; 89(3):506-12. PubMed ID: 12624635
[TBL] [Abstract][Full Text] [Related]
49. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation.
Inoue T; Hikichi Y; Morooka T; Yoshida K; Fujimatsu D; Komoda H; Kameda M; Nonaka M; Sohma R; Hashimoto S; Node K
Platelets; 2006 Sep; 17(6):416-20. PubMed ID: 16973503
[TBL] [Abstract][Full Text] [Related]
50. Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention.
Kaufmann J; Wellnhofer E; Kappert K; Urban D; Meyborg H; Hauptmann T; Müller A; Meixner M; Graf K; Fleck E; Stawowy P
Coron Artery Dis; 2013 Jun; 24(4):312-20. PubMed ID: 23549485
[TBL] [Abstract][Full Text] [Related]
51. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
[TBL] [Abstract][Full Text] [Related]
52. Platelet activation and pneumonia: is soluble p-selectin the right marker?
Gurbel PA; Kreutz RP; Bliden KP; Tantry US
J Am Coll Cardiol; 2015 Apr; 65(14):1492-3. PubMed ID: 25857923
[No Abstract] [Full Text] [Related]
53. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
Hung MJ; Cherng WJ; Cheng CW; Li LF
Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
[TBL] [Abstract][Full Text] [Related]
54. Reply: platelet activation and pneumonia: is soluble p-selectin the right marker?
Violi F; Calvieri C; Falcone M; Taliani G; Cangemi R;
J Am Coll Cardiol; 2015 Apr; 65(14):1493-4. PubMed ID: 25857924
[No Abstract] [Full Text] [Related]
55. Relation of platelet activation to coronary angiographic severity and collateralization.
Tan KT; Tayebjee MH; Macfadyen RJ; Lip GY
Am J Cardiol; 2005 Jul; 96(2):208-10. PubMed ID: 16018843
[TBL] [Abstract][Full Text] [Related]
56. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain.
Pizzulli L; Yang A; Martin JF; Lüderitz B
Eur Heart J; 1998 Jan; 19(1):80-4. PubMed ID: 9503179
[TBL] [Abstract][Full Text] [Related]
57. The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.
Gurbel PA; Bliden KP
Thromb Res; 2003; 112(1-2):9-12. PubMed ID: 15013266
[TBL] [Abstract][Full Text] [Related]
58. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
59. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting.
Wilczyński M; Wybraniec MT; Sanak M; Góral J; Mizia-Stec K
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):178-186. PubMed ID: 29107589
[TBL] [Abstract][Full Text] [Related]
60. Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction.
Seizer P; Fuchs C; Ungern-Sternberg SN; Heinzmann D; Langer H; Gawaz M; May AE; Geisler T
Platelets; 2016; 27(2):155-8. PubMed ID: 26084004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
